| Financial Year |
March 31 2023 |
| Monetary Funds |
333,377,470.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,392,834.82 |
| Accounts Receivable |
403,977,688.01 |
| Advances to Suppliers |
48,779,479.16 |
| Other Receivables |
30,843,903.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
870,925,206.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,750,142.43 |
| Total Current Assets |
1,837,095,986.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
210,873,307.72 |
| Under-construction Projects |
295,597,553.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
109,312,182.07 |
| R&D expenses |
-- |
| Goodwill |
25,832,212.47 |
| Long-Term Deferred and Prepaid Expenses |
4,805,987.47 |
| Deferred Income Tax Assets |
19,590,565.23 |
| Other Non-Current Assets |
10,356,110.00 |
| Sub-Total of Non-Current Assets |
704,117,399.52 |
| Total Assets |
2,541,213,386.09 |
| Short-Term Loans |
143,142,680.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
90,871,237.88 |
| Accounts Payable |
363,516,580.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,379,887.59 |
| Taxes Payable |
9,991,900.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,315,753.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,509,233.44 |
| Other Current Liabilities |
38,151,065.32 |
| Sub-Total of Current Liabilities |
1,322,999,527.07 |
| Long-term Loans |
104,082,291.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,824,597.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
128,591,652.63 |
| Total Liabilities |
1,451,591,179.70 |
| Paid-In Capital(Or Share Stock) |
497,756,637.00 |
| Capital Surplus |
343,423,302.63 |
| Surplus Reserve |
54,274,678.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
151,878,131.04 |
| Minority Stockholder's Interest |
42,289,457.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,047,332,748.72 |
| Owner's Equity（Stockholder's Equity） |
1,089,622,206.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,541,213,386.09 |
